DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Orencia (Abatacept) - Current Clinical Trials

 
 



Orencia Related Clinical Trials

Efficacy, Pharmacokinetics, Safety and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japan [Recruiting]

Pharmacokinetic Study to Compare the Blood Levels of Abatacept Manufactured at Lonza Biologics to the Blood Levels of Abatacept Manufactured at the Devens, MA Facility of Bristol-Myers Squibb [Not yet recruiting]

Efficacy and Safety of Abatacept Subcutaneous (SC) in Combination With Methotrexate in Adults With Very Early Rheumatoid Arthritis (RA) [Recruiting]

Abatacept for Treating Adults With Giant Cell Arteritis and Takayasu's Arteritis [Recruiting]

Vaccination Study of Abatacept (BMS-188667) for Normal Healthy Volunteers [Completed]

Study to Evaluate The Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy [Recruiting]

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis [Recruiting]

Abatacept Post-marketing Clinical Study in Japan [Recruiting]

Abatacept Versus Adalimumab Head-to-Head [Recruiting]

Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients [Recruiting]

Korean Post-marketing Surveillance for Orencia® [Recruiting]

CTLA4-Ig (Abatacept)for Prevention of Abnormal Glucose Tolerance and Diabetes in Relatives At -Risk for Type 1 [Recruiting]

A Rheumatoid Arthritis Study to Assess Early Response to Abatacept+MTX as Defined by Improvement of Synovitis Measures by Power Doppler Ultrasonography [Recruiting]

A Cooperative Clinical Study of Abatacept in Multiple Sclerosis [Recruiting]

A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome [Recruiting]

Abatacept Treatment in Polymyositis and Dermatomyositis [Recruiting]

Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis [Not yet recruiting]

Study on the Safety of Abatacept in Relapsing Polychondritis [Recruiting]

Costimulation Inhibition in Asthma [Recruiting]

A Study of Abatacept in Patients With Active Ulcerative Colitis [Recruiting]

Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis [Recruiting]

Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-Biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy [Active, not recruiting]

Monitoring Epstein-Barr Virus (EBV) Load in Rheumatoid Arthritis Patients Treated With New Immunosuppressive Drugs [Recruiting]

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis [Recruiting]

Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis [Recruiting]

Study to Assess Steady-State Trough Concentrations, Safety, and Immunogenicity of Abatacept After SC Administration to Subjects With RA [Active, not recruiting]

Impact of Subcutaneous Abatacept in Rheumatoid Arthritis Assessing Inhibition of Structural Damage [Recruiting]

A Phase III Study of Abatacept in Japanese Subjects With Rheumatoid Arthritis [Recruiting]

Phase IIIB Switching From Intravenous to Subcutaneous Study [Recruiting]

Safety Study of Abatacept to Treat Refractory Sarcoidosis [Recruiting]

Phase I/II Multiple-Dose LEA29Y vs CTLAG4Ig vs Placebo in Rheumatoid Arthritis [Completed]

Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. [Completed]

Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis [Recruiting]

BMS-188667 in Children and Adolescents With Juvenile Rheumatoid Arthritis [Completed]

A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate [Recruiting]

A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Recruiting]

The Study of Abatacept in Combination With Etanercept [Completed]

A Study of Abatacept in Patients With Active Crohn's Disease [Recruiting]

Abatacept in ANCA Associated Vasculitis [Recruiting]

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis [Completed]

An Exploratory Study of Changes in Synovial Immune Responses Following BMS-188667 Therapy in Subjects With Active Rheumatoid Arthritis on Background DMARDs Who Have Failed Anti-TNF Therapy [Completed]

Safety and Efficacy of Abatacept Versus Placebo in Subjects With Psoriatic Arthritis [Recruiting]

A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) [Recruiting]

An Observational Registry of Abatacept in Patients With Juvenile Idiopathic Arthritis [Not yet recruiting]

Phase III Study in China - Tolerance [Recruiting]

SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. [Not yet recruiting]

A Phase III Study of Abatacept in Patients With Rheumatoid Arthritis, With an Inadequate Response to Methotrexate [Recruiting]

Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients [Active, not recruiting]

Remission in Early Rheumatoid Arthritis [Active, not recruiting]

Phase II Randomized, Double-Blind, Placebo-Controlled Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris [Completed]

Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) [Not yet recruiting]

Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday [Not yet recruiting]

Abatacept for Patients With Inflammatory Arthritis Associated With Sj�gren's Syndrome: an Open-Label Phase II Study [Recruiting]

Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone [Completed]

Long-term Experience With Abatacept SC in Routine Clinical Practice [Recruiting]

A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) [Recruiting]

Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background [Recruiting]

Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis [Not yet recruiting]

Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome [Recruiting]

TOward the Lowest Effective DOse of Abatacept or Tocilizumab [Recruiting]

Abatacept Reduced Intensity for Non-Malignant Diseases [Recruiting]

Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) [Recruiting]

Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant [Recruiting]

Abatacept as GVHD Prophylaxis Phase 2 [Recruiting]

Comparability DE vs CD-CHO1 [Completed]

Abatacept in the Treatment of Uveitis [Recruiting]

Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis [Not yet recruiting]

Open-label Pilot Study of Abatacept for the Treatment of Vitiligo [Not yet recruiting]

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata [Recruiting]

Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis [Recruiting]

Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan [Recruiting]

Phase I Study of BMS-188667 (CTLA4Ig) in Patients With Psoriasis Vulgaris [Completed]

A Study to Assess the Pharmacokinetics, Immunogenicity and Safety of Escalating Doses of BMS-188667 Given as a Single Intravenous Infusion to Patients With Psoriasis Vulgaris [Completed]

Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes Mellitus [Recruiting]

A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis [Completed]

A Phase III Study of BMS-188667 in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate [Completed]

Phase IIIB Subcutaneous Missed Dose Study [Recruiting]

LEA29Y (Belatacept) Emory Edmonton Protocol [Recruiting]

A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-Remitting Multiple Sclerosis [Terminated]

CTLA4IG With Methotrexate- Phase IIB - Long Term [Completed]

Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis [Recruiting]

Belatacept Post Depletional Repopulation to Facilitate Tolerance [Recruiting]

A Belatacept Compassionate Use Study for Patients With a Kidney Transplant [Available]

Belatacept to Prevent Organ Rejection in Kidney Transplant Patients [Recruiting]

Study Comparing the Safety and Efficacy of BMS-224818 to Cyclosporine, in Patients Receiving a Kidney Transplant, When Used in Combination With CellCept, Simulect, and Corticosteroids. [Completed]

A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids [Recruiting]

Study of Belatacept in Subjects Who Are Undergoing a Renal Transplant [Active, not recruiting]

Belatacept Evaluation of Nephroprotection and Efficacy as First-Line Immunosuppression (BENEFIT) [Active, not recruiting]

Study of Belatacept (BMS-224818) With a Steroid-Free Regimen in Subjects Undergoing Kidney Transplantation [Recruiting]

Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients [Recruiting]

Belatacept Pharmacokinetic Trial in Renal Transplantation [Recruiting]

Belatacept in Liver Transplant Recipients [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014